FIG 4.
Overexpression of ELO2 changed complex sphingolipid contents. (A to F) Phospholipid content (including phosphatidylserine [PS], phosphatidic acid [PA], phosphatidylinositol [PI], phosphocholine [PC], phosphatidylglycerol [PG], and phosphatidylethanolamine [PE]) changed in strain XCG002 and strain XCG010 at 0 M and 1.0 M NaCl. (G) The ratio of complex sphingolipid (including phosphorylceramide [IPC], mannosylinositol phosphorylceramide [MIPC], mannosyldiinositol phosphorylceramide [M(IP)2C] content in strain XCG010) to that of control strain XCG002 changed at 0 M and 1.0 M NaCl. All data are presented as mean values from three independent experiments. Error bars indicate the standard deviations. *, P < 0.05; **, P < 0.01.